IPO News & Commentary
Get the latest insights on new stocks
- SPAC TCGX Acquisition II prices $100 million IPO, targeting healthcare in Asia 10/16/26
- City Therapeutics prices upsized IPO at $18, the midpoint of the range 10/16/26
- Small molecule biotech Iambic Therapeutics prices IPO at $16, the midpoint of the range 10/15/26
- Metal powder producer Amaero prices downsized US IPO at $4.25 per share 10/14/26
- Tungsten Miners Weigh IPOs Following Price Surge 10/14/26
- Cardiac medical device developer BioVentrix withdraws $17 million IPO 10/14/26
- Biotech-focused SPAC Frazier Life Sciences Acquisition II prices $75 million IPO 10/14/26
See more
IPO News By Industry
- Christian-focused connectivity firm Patriot Mobile files for a $10 million IPO 10/09/26
- Hong Kong-based marketing firm AM PM Group doubles shares offered ahead of $34 million US IPO 08/27/26
- Hong Kong digital marketing provider Poche Technology ups range to $5 to $7 ahead of $38 million US IPO 08/06/26
NYSE IPO News
- Pan-Asian travel booking platform Klook Technology withdraws estimated $400 million US IPO 10/16/26
- IPO Weekly Weigh-in: Why investors said no to this $3.5B AI IPO 10/14/26
- Emerging markets fintech OPay files for an estimated $500 million US IPO 10/09/26
- Cavity treatment provider vVardis files for an estimated $200 million US IPO 10/09/26
- SPAC Calm Seas Acquisition lowers units offered by 25% ahead of $200 million IPO 10/08/26
Nasdaq IPO News
- US IPO Weekly Recap: Biotechs City Therapeutics and Iambic headline the week’s pricings 10/16/26
- SPAC TCGX Acquisition II prices $100 million IPO, targeting healthcare in Asia 10/16/26
- City Therapeutics prices upsized IPO at $18, the midpoint of the range 10/16/26
- Small molecule biotech Iambic Therapeutics prices IPO at $16, the midpoint of the range 10/15/26
- Metal powder producer Amaero prices downsized US IPO at $4.25 per share 10/14/26
Be the in-house IPO Expert
Our clients are focused on catalyzing growth and creating value.
Not scouring the web for IPO data.
Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.
US IPO Week Ahead: IPO calendar stays quiet ahead of potential Anthropic filing
No IPOs are currently scheduled for the week ahead as the year’s next mega IPO potentially comes into view. Reportedly targeting a listing in mid-November, Anthropic could file as early as this coming Friday. The AI giant has been the subject of nonstop...read more
US IPO Weekly Recap: Biotechs City Therapeutics and Iambic headline the week’s pricings
Three IPOs and two SPACs priced this week, and two SPACs submitted filings. City Therapeutics (CTY) priced its upsized IPO at the midpoint to raise $200 million at a $1.0 billion market cap. City Therapeutics is a Phase 1 biotech developing RNA interference...read more
Pan-Asian travel booking platform Klook Technology withdraws estimated $400 million US IPO
Klook Technology, a pan-Asian online travel booking platform, withdrew its plans for an initial public offering on Friday. It originally filed in November 2025 with an estimated deal size of $400 million. It hadn't updated its prospectus since then. Klook ...read more